Fatigue, self-efficacy and psychiatric symptoms influence the quality of life in patients with myasthenia gravis in Tianjin, China
- 1 September 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 79, 84-89
- https://doi.org/10.1016/j.jocn.2020.06.023
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Fatigue in patients with myasthenia gravisZeitschrift für Neurologie, 2018
- Rationale for the clinical guidelines for myasthenia gravis in JapanAnnals of the New York Academy of Sciences, 2018
- Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravisJournal of Clinical Neuroscience, 2018
- Myasthenia gravis: new developments in research and treatmentCurrent Opinion in Neurology, 2017
- Myasthenia gravis: subgroup classification and therapeutic strategiesThe Lancet Neurology, 2015
- Patient Self-management of Chronic Disease in Primary CareJAMA, 2002
- Chronic Disease Self-Management ProgramMedical Care, 2001
- Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurementsNeurological Sciences, 2001
- Quality of life and well‐being of patients with myasthenia gravisMuscle & Nerve, 2001
- Evidence Suggesting That a Chronic Disease Self-Management Program Can Improve Health Status While Reducing HospitalizationMedical Care, 1999